HEALTHglobal
STAT+: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy
Single source
Updated 3 hours ago
First seen March 19, 2026 04:15:45Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut costs and expand access.